Chlorpromazine Hydrochloride Recalls

18 recalls found for Chlorpromazine Hydrochloride. Check if any of your products are affected.

Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Chlorpromazine Hydrochloride 200 mg Recall Involves 1,394 Blister Packs (2025)

Major Pharmaceuticals recalled 1,394 blister packs of Chlorpromazine Hydrochloride Tablets, 200 mg, distributed nationwide. The recall cites CGMP deviations with the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. Healthcare providers and patients are urged to stop using the product and await guidance from Major Pharmaceuticals and Rugby Laboratories.

Chlorpromazine Hydrochloride
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Chlorpromazine Hydrochloride 100 mg Recall 2025 — 866 Blister Packs Nationwide

Major Pharmaceuticals recalled 866 Chlorpromazine Hydrochloride 100 mg tablets distributed nationwide after CGMP deviations allowed N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. The impurity detected raises safety concerns for ongoing use. Stop using the product immediately and contact Harvard Drug Group LLC dba Major Pharmaceuticals or Rugby Laboratories for guidance and,

Major Pharmaceuticals
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Chlorpromazine 25 mg Tablets Recalled for Nitrosamine Contamination (1256 Bls,

Major Pharmaceuticals recalled 1,256 blister packs of Chlorpromazine Hydrochloride tablets, 25 mg, sold nationwide in the United States. A CGMP deviation led to the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake. Healthcare providers and patients should stop using the product and contact Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories for next-步

Chlorpromazine Hydrochloride
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Chlorpromazine Hydrochloride 50 mg Tablets Recalled for Nitrosamine Impurity (

Major Pharmaceuticals, via The Harvard Drug Group LLC, recalled 506 blister packs of Chlorpromazine Hydrochloride tablets, 50 mg, distributed nationwide. A CGMP deviation shows the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. Stop using the product and contact the Harvard Drug Group or Rugby Laboratories for guidance.

Major Pharmaceuticals
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Chlorpromazine Hydrochloride 25 mg Tablets Recall 2025 for CGMP Deviations

Major Pharmaceuticals recalled 2,064 blister packs of Chlorpromazine Hydrochloride Tablets, 25 mg, sold nationwide through healthcare providers. The recall follows CGMP deviations that allowed the presence of N-Nitroso Desmethyl Chlorpromazine above the allowed limit. Stop using the product immediately and await guidance from Major Pharmaceuticals or your healthcare provider.

Major Pharmaceuticals
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Chlorpromazine Hydrochloride 10 mg Tablets Recalled for Nitrosamine Impurity (2025)

Zydus Lifesciences and Zydus Pharmaceuticals US recall Chlorpromazine Hydrochloride Tablets, 10 mg, 100-count bottles sold nationwide in the United States after detecting an impurity above acceptable intake. The impurity is N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and contact the manufacturer for guidance.

Chlorpromazine Hydrochloride
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride 25 mg 100-count Tablets Recalled Nationwide (2025)

Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride tablets, 25 mg, 100-count bottles distributed nationwide by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. The recall cites CGMP deviations and the presence of N-Nitroso Desmethyl Chlorpromazine above the acceptable intake limit. Stop using the product and contact your healthcare provider or Zydus Pharmaceuticals (USA) Inc. for

Chlorpromazine Hydrochloride
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Chlorpromazine Hydrochloride 200 mg Recall Expands Nationwide Over CGMP Deviations

The FDA confirms a nationwide recall of Zydus Lifesciences Chlorpromazine Hydrochloride tablets 200 mg (NDC 70710-1133-1) distributed by Zydus Pharmaceuticals USA. The recall cites CGMP deviations and the presence of N-Nitroso Desmethyl Chlorpromazine above acceptable intake. Consumers and healthcare providers should stop using the product immediately and contact the distributor for guidance.

Chlorpromazine Hydrochloride
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

873 Cartons of Chlorpromazine Hydrochloride Tablets Recalled Due to Foreign Substance Risk

American Health Packaging recalled 873 cartons of Chlorpromazine Hydrochloride Tablets, USP, 200 mg, after foreign substances were detected in product packaging. A specific lot of auxiliary polyester coil contained a micro-organism, posing a high health risk. Consumers should stop using the product immediately and contact their healthcare provider for guidance.

Chlorpromazine Hydrochloride
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

Chlorpromazine Hydrochloride Tablets Recalled Nationwide for Foreign Substance in Packaging Lot 1022

A high-severity recall covers chlorpromazine hydrochloride tablets distributed nationwide by American Health Packaging. A foreign substance linked to a polyester coil packaging component was detected at the manufacturing site. No tablets were contaminated. Stop using the product and contact the distributor for guidance.

CHLORPROMAZINE HYDROCHLORIDE
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

Chlorpromazine Hydrochloride 25 mg Tablets Recalled Nationwide Over Foreign Substance in Packaging

A recall of chlorpromazine hydrochloride tablets is active nationwide in the United States. A specific lot of packaging material to coils used in manufacturing contained a foreign substance with a microorganism detected. Tablets themselves tested negative for microorganisms. Consumers and healthcare providers should stop using the product immediately and contact Amerisource Health Services LLC or

CHLORPROMAZINE HYDROCHLORIDE
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

Chlorpromazine Hydrochloride Tablets Recalled Over Foreign Substance Found in Packaging Coil (High-R

Chlorpromazine Hydrochloride tablets distributed nationwide by American Health Packaging are recalled after a polyester coil used in packaging showed presence of a micro-organism in a specific lot. No tablets were contaminated. Consumers and healthcare providers should stop using this product immediately and contact Amerisource Health Services LLC for guidance.

Chlorpromazine Hydrochloride
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

AvKare Chlorpromazine Hydrochloride 50 mg Tablets Recalled for Foreign Substance Contamination (2025

AvKare recalled 1,512 cartons of CHLORPROMAZINE HYDROCHLORIDE 50 mg tablets distributed nationwide in the U.S. for the presence of a foreign substance. The recall is active as of Sept. 17, 2025. Consumers and healthcare providers should stop using this product immediately and contact AvKARE or a healthcare provider for guidance.

AvKare
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

Amneal Chlorpromazine Hydrochloride Recall 2025: 14,923 Bottles Over Packaging Contamination

Amneal Pharmaceuticals recalled 14,923 bottles of Chlorpromazine Hydrochloride 100 mg tablets sold nationwide in the United States. A packaging coil used in the product’s packaging was found to contain a microorganism. No microorganism was detected on any tablets. Stop using the product and contact Amneal or your healthcare provider for guidance.

Chlorpromazine Hydrochloride
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

Amneal Chlorpromazine Hydrochloride 25 mg 100-count Recalled in 2025 for Packaging Contamination

Amneal Pharmaceuticals LLC is recalling 7,228 bottles of CHLORPROMAZINE HYDROCHLORIDE tablets sold nationwide in the United States. Packaging coils used in the bottles tested positive for a microorganism, though no tablets were contaminated. Stop using this product immediately and contact Amneal or your healthcare provider for guidance.

Chlorpromazine Hydrochloride
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

Amneal Chlorpromazine Hydrochloride 50 mg Tablets Recall 2025 (13,130 Bottles)

Amneal Pharmaceuticals recalled 13,130 bottles of CHLORPROMAZINE HYDROCHLORIDE 50 mg tablets distributed nationwide in the USA. A specific lot of auxiliary polyester coil used in packaging was found to contain a microorganism. No microorganism was detected on any tablets. Consumers and healthcare providers should stop using this product immediately and await further instructions from Amneal or a H

Chlorpromazine Hydrochloride
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

Chlorpromazine Hydrochloride 200 mg Recall Expanded After Packaging Contamination Found in 3,363 JDS

Amneal Pharmaceuticals products containing chlorpromazine hydrochloride are recalled nationwide after the FDA-linked notice identifies a foreign substance in packaging material. No tablets were contaminated. The recall was issued August 18, 2025 and updated September 10, 2025. Consumers and healthcare providers should stop using the affected lots immediately and contact Amneal for guidance.

Chlorpromazine Hydrochloride
Presence of
Read more